ATE120209T1 - Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit. - Google Patents

Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.

Info

Publication number
ATE120209T1
ATE120209T1 AT88901526T AT88901526T ATE120209T1 AT E120209 T1 ATE120209 T1 AT E120209T1 AT 88901526 T AT88901526 T AT 88901526T AT 88901526 T AT88901526 T AT 88901526T AT E120209 T1 ATE120209 T1 AT E120209T1
Authority
AT
Austria
Prior art keywords
fsh
isolation
single chain
follicular fluid
chain proteins
Prior art date
Application number
AT88901526T
Other languages
English (en)
Inventor
Kretser David Morritz De
Henry George Burger
Milton Thomas William Hearn
David Mark Milne-Robertson
Richard Edward Hugh Wettenhall
Robert Ian Mclachlan
Vos Fiona De
Original Assignee
Biotech Australia Pty Ltd
Univ Monash
Prince Henrys Inst Med Res
St Vincents Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Monash, Prince Henrys Inst Med Res, St Vincents Inst Med Res filed Critical Biotech Australia Pty Ltd
Application granted granted Critical
Publication of ATE120209T1 publication Critical patent/ATE120209T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88901526T 1987-01-29 1988-01-29 Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit. ATE120209T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPI008187 1987-01-29
AUPI252587 1987-06-17
AUPI576587 1987-12-07
AUPI576687 1987-12-07

Publications (1)

Publication Number Publication Date
ATE120209T1 true ATE120209T1 (de) 1995-04-15

Family

ID=27424192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88901526T ATE120209T1 (de) 1987-01-29 1988-01-29 Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.

Country Status (7)

Country Link
US (1) US5470826A (de)
EP (1) EP0299050B1 (de)
JP (1) JP2802633B2 (de)
AT (1) ATE120209T1 (de)
AU (1) AU610858B2 (de)
DE (1) DE3853383T2 (de)
WO (1) WO1988005789A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368992B1 (de) * 1988-05-31 1995-02-15 Biotechnology Australia Pty. Ltd. Wirkung von hormonen
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
US5658876A (en) * 1994-04-28 1997-08-19 The General Hospital Corporation Activin antagonists as novel contraceptives
US6040431A (en) 1995-06-07 2000-03-21 Stryker Corporation Single chain analogs of the TGF-β superfamily (morphons)
US6407205B1 (en) * 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
WO2001029079A1 (en) 1999-10-18 2001-04-26 Prince Henry's Institute Of Medical Research IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN
AUPR638101A0 (en) * 2001-07-13 2001-08-09 Bioa Pty Limited Composition and method for treatment of disease
JP2007507429A (ja) 2003-10-06 2007-03-29 モナシュ ユニバーシティー 治療方法
US20100055730A1 (en) * 2006-05-05 2010-03-04 Anny Usheva-Simidjiyska Methods for the Diagnosis and Treatment of Female Infertility Using Molecular Markers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215130A (en) * 1977-05-31 1980-07-29 Richardson-Merrell Inc. Antihypertensive compositions of N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
US5041538A (en) * 1987-08-28 1991-08-20 The Salk Institute For Biological Studies Mammalian follistatin
US5037805A (en) * 1989-03-20 1991-08-06 The Salk Institute For Biological Studies Methods of contraception

Also Published As

Publication number Publication date
EP0299050A4 (de) 1990-04-10
AU1242188A (en) 1988-08-24
EP0299050A1 (de) 1989-01-18
DE3853383D1 (de) 1995-04-27
JPH01502662A (ja) 1989-09-14
JP2802633B2 (ja) 1998-09-24
AU610858B2 (en) 1991-05-30
US5470826A (en) 1995-11-28
EP0299050B1 (de) 1995-03-22
WO1988005789A1 (en) 1988-08-11
DE3853383T2 (de) 1995-07-27

Similar Documents

Publication Publication Date Title
ES8306797A1 (es) Un metodo para producir un polipeptido.
DK322188D0 (da) Fremgangsmaade til fremstilling af protein
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
PT94381A (pt) Processo para a preparacao de uma composicao contendo um imunogeno para tratamentos antialergicos
NO924310L (no) Nevrobeskyttende indolon- og beslektede derivater
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
ATE120209T1 (de) Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
ES2016920A4 (es) Procedimiento de realizacion de barras anti-torsion por encolado in situ de cojinetes elasticos y barras anti-torsion realizadas segun el procedimiento.
ATE246248T1 (de) Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
ATE110074T1 (de) Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.
FI910653A0 (fi) Synteettiset reseptorianalogit
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
GB1520162A (en) Bone joint prosthesis
KR830005863A (ko) 인체 융모성선자격 호르몬의 제조방법
DE3382718D1 (de) Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.
ATE63904T1 (de) Azolderivate, geeignet zur bekaempfung von pflanzen-krankheiten.
SE8700156L (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
KR910003095A (ko) 사람의 단백질 c변이체 및 이의 제조방법
DE3880520D1 (de) Rekombinantes plasmid fuer die expression von l-phenylalanin-ammonialyase und transformierte staemme, die es enthalten.
BG98238A (bg) Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
NL177209B (nl) Werkwijze voor het bereiden van reukstofpreparaten op basis van tricyclo(5.2.1.0Ÿ2Ÿ,Ÿ6Ÿ-)decyl-8-derivaten, alsmede werkwijze voor het bereiden van bij de bereiding van dergelijke reukstofpreparaten toe te passen tricyclo(5.2.1.0Ÿ2Ÿ,Ÿ6Ÿ-)decyl-8-derivaten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties